Eosinophilia

Last updated: 19 May 2026
Reviewed by: Specialist doctors from the Elfcare quality team

Have you been experiencing persistent itching, unexplained skin rashes, recurring digestive discomfort, or a cough that just will not clear despite treatment? Perhaps you have noticed these symptoms come and go without an obvious trigger. These can be early signs that a specific type of white blood cell called an eosinophil is elevated in your blood, signalling that your immune system is responding to something it has not yet been able to resolve.

Eosinophilia is frequently discovered incidentally during a routine blood test. In most cases it reflects an allergic condition or a parasitic infection, both of which are very treatable. In a smaller but important proportion of cases it points to a more serious underlying condition affecting the organs. A full blood count identifies it directly, and the level of elevation guides what investigation is needed next.

Book your consultation now to test your vitamin D levels

What is eosinophilia?

Eosinophils are a type of white blood cell that play a central role in the immune response to parasites, allergens, and certain inflammatory conditions. They are produced in the bone marrow and normally account for a small proportion of circulating white blood cells. A normal eosinophil count is below 0.5 x 10⁹/L. Eosinophilia is defined as a count above this threshold.

The severity of eosinophilia is clinically important:

  • Mild eosinophilia (0.5 to 1.5 x 10⁹/L) is the most common form, most frequently caused by allergic conditions such as asthma, hay fever, or eczema, or by a recent parasitic infection.

  • Moderate eosinophilia (1.5 to 5.0 x 10⁹/L) warrants more systematic investigation for underlying causes including parasitic infection, drug reactions, inflammatory bowel disease, and connective tissue disorders.

  • Severe eosinophilia or hypereosinophilia (above 5.0 x 10⁹/L) raises concern for organ damage from eosinophil tissue infiltration, particularly affecting the heart, lungs, skin, and nervous system. This level requires specialist assessment.

Symptoms of eosinophilia

Eosinophilia itself may cause no symptoms at all, particularly at mild levels. When symptoms occur they typically reflect either the underlying condition driving eosinophil elevation or, in severe cases, direct organ damage from eosinophil tissue infiltration. Common signs include:

  • Persistent itching or skin rashes, including urticaria and eczema flares

  • Chronic or recurrent cough, wheezing, or breathlessness from airway inflammation

  • Nasal congestion, sneezing, or rhinitis

  • Abdominal discomfort, bloating, or diarrhoea

  • Fatigue and general malaise

  • In severe eosinophilia: chest pain or breathlessness from cardiac involvement, neurological symptoms, or skin thickening

What causes eosinophilia?

Eosinophilia results from increased production of eosinophils in the bone marrow, most commonly driven by allergic or immune stimulation. Contributing causes include:

  • Allergic conditions are the most common cause in developed countries. Asthma, allergic rhinitis, eczema, and food allergies all drive chronic eosinophil elevation through ongoing IgE-mediated immune activation.

  • Parasitic infections are the most common cause globally. Tissue-invasive parasites including roundworm, hookworm, toxocara, and strongyloides trigger a sustained eosinophil response. Travel to or residence in tropical regions significantly raises the likelihood of parasitic eosinophilia.

  • Drug reactions from antibiotics, non-steroidal anti-inflammatory drugs, antiepileptic medications, and certain other drugs can trigger eosinophilia as an immune response.

  • Inflammatory bowel disease particularly eosinophilic oesophagitis, eosinophilic gastroenteritis, and Crohn's disease cause local and sometimes systemic eosinophilia.

  • Connective tissue and autoimmune disorders including lupus, rheumatoid arthritis, and vasculitis can cause moderate eosinophilia.

  • Malignancy including lymphoma, particularly Hodgkin lymphoma, and solid tumours can cause reactive eosinophilia through cytokine release.

  • Hypereosinophilic syndrome is a rare primary condition in which eosinophils proliferate without an identifiable external trigger and infiltrate organs, causing potentially serious cardiac, neurological, and pulmonary damage.

  • Adrenal insufficiency reduces cortisol, which normally suppresses eosinophil production. Elevated eosinophils with fatigue and low blood pressure should prompt cortisol assessment.

How is eosinophilia detected?

Eosinophilia is detected directly through a full blood count, with additional markers helping identify the underlying cause and assess for organ involvement.

Blood tests Elfcare's panel includes eosinophil count as part of the full blood count, alongside supporting markers:

  • Eosinophil count and full differential: is the primary marker. The absolute eosinophil count determines severity and guides the urgency of further investigation.

  • Total IgE: reflects overall allergic immune activity. Markedly elevated IgE alongside eosinophilia strongly supports an allergic or parasitic cause.

  • CRP: reflects systemic inflammation. Elevated CRP with eosinophilia supports an active inflammatory, infective, or malignant cause.

  • Full blood count: assesses whether eosinophilia is isolated or accompanied by other blood count abnormalities suggesting a primary bone marrow disorder.

  • ALT, AST, and ALP: assess liver involvement, relevant when drug-induced or parasitic eosinophilia with hepatic infiltration is suspected.

  • Creatinine and eGFR: assess kidney function, relevant when autoimmune or hypereosinophilic conditions with renal involvement are considered.

  • Cortisol: screens for adrenal insufficiency, an underappreciated cause of eosinophilia.

  • tTG-IgA: screens for coeliac disease and eosinophilic gastrointestinal conditions that cause both intestinal inflammation and eosinophilia.

  • Vitamin B12: is elevated in some myeloproliferative conditions causing primary eosinophilia and provides useful context.

Why early detection matters

Mild eosinophilia from allergy is common and manageable, but the same blood finding can also be the first indicator of a parasitic infection causing silent organ damage, a drug reaction requiring medication change, or a haematological malignancy. In hypereosinophilic syndrome, persistent undetected eosinophil infiltration of the heart muscle can cause irreversible cardiac damage long before symptoms develop. Identifying eosinophilia early, determining its cause, and monitoring for organ involvement in more severe cases prevents both the immediate and long-term consequences of untreated disease.

How Elfcare can help

Elfcare's full blood count includes eosinophil count and differential as standard, making eosinophilia a directly detectable finding in every health check. Our panel covers IgE, CRP, liver and kidney function, tTG-IgA, and metabolic markers, providing the context needed to identify the most common underlying causes and distinguish benign allergic eosinophilia from findings that require specialist assessment.

If our blood tests identify eosinophilia or related findings, we take care of further diagnostics or refer you to the appropriate specialist.

Book a consultation to learn more

Summary

Eosinophilia is an elevation in eosinophil count that most commonly reflects allergic conditions or parasitic infection but can also signal inflammatory bowel disease, autoimmune conditions, drug reactions, malignancy, or rare primary bone marrow disorders. It is directly detectable through a full blood count, a standard component of Elfcare's blood panel. Our comprehensive panel covers the allergic, inflammatory, and organ function markers needed to identify the underlying cause. Detecting and addressing eosinophilia early prevents both the complications of the underlying condition and the organ damage that severe untreated eosinophilia can cause.

Last updated: 19 May 2026
Reviewed by: Specialist doctors from the quality team at Elfcare

FAQ

  • Eosinophilia is an elevated eosinophil count, above 0.5 x 10⁹/L. Eosinophils are white blood cells involved in the immune response to allergens and parasites. Mild eosinophilia is common and usually reflects allergic conditions. Moderate to severe elevation warrants investigation for parasitic infection, inflammatory conditions, drug reactions, malignancy, or rare primary bone marrow disorders.

  • Persistent itching, skin rashes, chronic cough, wheezing, nasal congestion, and digestive discomfort. Many people with mild eosinophilia have no symptoms at all. Severe eosinophilia can cause organ damage affecting the heart, lungs, skin, and nervous system.

  • Allergic conditions including asthma and eczema are the most common cause in developed countries. Parasitic infections are the most common cause globally. Drug reactions, inflammatory bowel disease, connective tissue disorders, malignancy, adrenal insufficiency, and hypereosinophilic syndrome are other important causes.

  • A full blood count with differential is the primary detection tool, identifying the absolute eosinophil count and its severity. Total IgE, CRP, liver and kidney function, and tTG-IgA help identify the underlying cause. Severe or persistent eosinophilia with organ symptoms prompts specialist assessment including cardiac and pulmonary evaluation.

  • Yes. Elfcare's full blood count includes eosinophil count and differential as standard. Our panel covers IgE, CRP, liver and kidney function, and tTG-IgA, providing the context needed to interpret the finding. If eosinophilia is identified, we take care of further diagnostics or refer you to the appropriate specialist.

  • Treatment depends entirely on the underlying cause. Allergic eosinophilia is managed with antihistamines, inhaled corticosteroids, or allergen avoidance. Parasitic eosinophilia is treated with targeted antiparasitic medication. Drug-induced eosinophilia resolves with medication change. Autoimmune and inflammatory causes are managed with immunosuppressive therapy. Hypereosinophilic syndrome is treated with corticosteroids or targeted biologic therapy depending on the subtype. Early identification and treatment prevents organ damage in severe cases.